Plasma vascular endothelial growth factor levels are a potential therapy-response biomarker for pancreatic cancer
VEGF as a potential therapy response biomarker will need to be tested in phase II randomized controlled trial.
Authors
- Hemant M. Kocher
- Oleg B. Blyuss (ORCID: https://orcid.org/0000-0002-0194-6389)
- Christine S. Hughes
Institutions
- Queen Mary University of London (GB)
- Sechenov University (RU)
- Barts Health NHS Trust (GB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fonc.2025.1672385
- Primary Topic
- Chemokine receptors and signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Barts Charity
- Medical Research Council